Dexamethasone, for example, is commonly co-prescribed in patients with brain tumors receiving DOACs and AEs and could amplify the DOAC AE DDI because it also induces P-gp and CYP3A4 [1,26]. Here, CYP3A4 is linked to brain neoplasm.